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ments. ConClusions: The body of literature from this 5-year period provides con-
tinued evidence of the benefits of a pharmacist within a PCMH to patients and 
health systems. This reemphasizes the need for future pharmacists to assume a 
greater role on the health care teams within PCMHs.
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GerMAny
Chase D.P.1, Mitar I.2, Oertelt-Prigione S.3, Hess N.4, Amelung V.E.1
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objeCtives: There is strong evidence that health management programs should 
be designed according to the need of a target population. Personalized medicine is 
currently a popular topic in health care debates, yet the basic differentiation into 
females and males is hardly found in programs of health insurances. This explora-
tive study aims at elucidating the opinion of German Statutory Health Insurance 
(SHI) managers on gender-specific care, to understand responsibilities and possible 
implementation opportunities. Methods: A questionnaire on the implementation 
of gender medicine in current health care landscape, based on literature review 
and expert consultations, was developed from April to June 2013. It includes open- 
and closed-ended questions on the following three topics: expectations/prioritiza-
tion, need for action and implementation. Forty-eight insurance managers of the 
largest German SHIs, covering over 95% of the market, were asked to complete a 
web-based survey, achieving a response rate of 57%. Descriptive analyses and intra-
group comparisons have been performed to assess statistical differences. Results: 
According to the insurance managers (76%), gender-specific care is not sufficiently 
incorporated into standard medical care. Respondents claim the responsibility lies 
with doctors and with their associations. Only 30% of respondents see an active 
contribution of health insurances as a prerequisite for a successful implementation 
of gender-specific care. The key success factors, according to insurance managers 
are: knowledge and acceptance by physicians, sufficient medical evidence, and 
the integration of gender aspects in treatment guidelines. ConClusions: German 
SHIs expect a significant governmental influence and/or support of self-governing 
bodies to achieve an incorporation of gender medicine in daily practice. In fact, 
they display a strong averseness to take primary responsibility for the integration 
of gender-specific approaches in their programs. Although insurance companies 
consider themselves only a subordinated instance, their positive perception of the 
topic should be integrated into the implementation process, as soon as critical 
hurdles in the medical field will be removed.
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objeCtives: Retina specialists currently have a choice of several effective anti-VEGF 
medications to treat neovascular age-related macular degeneration (AMD). However, 
these medications vary in price, sustainability and (more controversially) safety and 
efficacy. This study examines the treatment pattern of 2 of the most commonly used 
drugs. Methods: This was a longitudinal evaluation of the treatment patterns for 
Medicare beneficiaries who received an anti-VEGF injection for AMD. We used the 
5% Part B and Outpatient Standard Analytical Files to evaluate intravitreal treatment 
of AMD along with a determination of the number of ophthalmologist specialists. 
Results were subdivided according to the type of anti-VEGF received: bevacizumab, 
ranibizumab or the combination of the two. Results: There were a total of 4,851 
beneficiaries evaluated with an average age in excess of 80 years. Most were female 
and almost all were white. Over a three-year period, there were an average of 15 
claims per patient. Patients that were treated with bevacizumab had the fewest 
claims over the three-year period (n= 11) compared to patients that were treated 
with ranibizumab (n= 15) or a combination of bevacizumab and ranibizumab (n= 20). 
Most patients remained in the cohort for the entire 36 months of follow-up. The 
median number of ophthalmologists seen per patient was about the same for the 
three drug groups. More subjects are seen by two ophthalmologists, but received 
their drug injections from only a single individual. By contrast, when two physi-
cians were involved, the number of drug claims was higher. Non-drug claims are 
higher as well. ConClusions: This study shows the differences in the pattern 
of bevacizumab and ranibizumab use. These differences may be associated with 
socioeconomic factors and/or with disease physiology. The understanding of these 
selective utilization patterns may have major implications on health care policies.
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objeCtives: To assess the effect of a cost-management component in a Medicare 
Part D MTM administrator-implemented program on total prescription drug costs 
over 3 years. Methods: The Targeted Intervention Program (TIP) monitors prescrip-
tion claims data to identify opportunities for cost saving and care improvement, 
and then periodically generates an electronic TIP-record that notifies the patient’s 
pharmacy of the situation. Pharmacists may successfully complete the TIP-record 
action (e.g. delivering a targeted medication review), return the TIP-record with-
out completion (e.g. lack of patient or provider cooperation), or ignore it. A cohort 
of Medicare Part D beneficiaries (N = 16,180) from two drug plans participated in 
the cost-management component of this program. Their TIP records from 2010 to 
2012 were analyzed using SAS. Total prescription drug cost, averaged over 3-month 
period in order to smooth the sporadic nature of prescription fills, was modeled 
as a function of the cumulative number of generated, returned, and successful 
objeCtives: Assessment was carried out to determine perceived health service 
leadership and management skills, competencies and ability possessed by health 
care managers working in level 3, 4 and 5 hospitals. Methods: Cluster sampling 
method was used where list of counties in Nyanza was compiled in November 
2013; three out of six counties were randomly selected, 8 hospitals and 2 county 
health offices purposively selected. Thirty two health care professionals at man-
agement positions were selected for assessment using self administered question-
naire. Information was collected on perception of skills, competencies, ability and 
knowledge possessed on pre-selected 24 leadership and management aspects. A 
five step Likert rating scale was used. SPSS computer program was used to analyze 
data and results presented in percentages, graphs and tables. Results: Assessment 
showed that all respondents perceived themselves to be fair, poor or very poor in at 
least 70% of 24 management and leadership skills and competency aspects. Forty 
seven percent had never attended any training on health service management and 
leadership before. Forty one percent of those who had attended similar training 
only attended once and training period was “too brief”. Ninety one percent said 
the training be sandwiched with international exposure of whom 66% were willing 
to raise own air ticket and accommodation. Leadership, financial, management of 
health care resources, ISO certification and communication skills were identified 
as top priority gaps health managers required urgent training. Forty one percent 
said the training will help them improve on quality of health care provided in their 
hospitals. ConClusions: The assessment concluded that majority of health care 
managers have not been adequately prepared to handle health service manage-
ment and leadership roles. Therefore ,there is need to equip them with these skills 
in order to be able to handle critical leadership challenges they face in their day to 
day professional experience.
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objeCtives: To evaluate the clinical impact of a pilot integrated care manage-
ment program consisting of nurses and pharmacists to provide medication review 
and consults over the phone to commercially insured members who were recently 
discharged from the hospital (Transitional Case Management or TCM group) or 
referred from nurses (Non-TCM group). Methods: A prospective cohort analysis 
was performed using pharmacy and medical claims data. Intervention members 
who participated in the pilot between 6/18/2012 and 6/14/2013 were matched to 
control members who did not participate in the pilot on a 1:1 basis using propen-
sity score matching. The propensity score model included member demograph-
ics, baseline health indicators, previous health care utilization, and other member 
characteristics. Continuous eligibility for at least 120 days before and 30 days after 
the intervention date was required. Outcomes included hospital or emergency room 
(ER) visits within 30 days, and resolution of drug issues, such as drug-drug inter-
actions (DDIs) and non-adherence, within 120 days of the intervention date. All 
outcomes were evaluated using logistic multivariable regression models. Results: 
A total of 274 TCM intervention members and 156 Non-TCM intervention mem-
bers were included in the analysis. After propensity matching, differences between 
the intervention and control groups were no longer statistically significant. TCM 
intervention members were significantly more likely than TCM control members 
to resolve at least one drug-related issue [odds ratio (OR)= 2.18 (95% CI: 1.47, 3.22)]. 
Specifically, the odds of resolving major/contraindicated DDIs were 42% higher 
among intervention members compared to controls [OR= 1.42 (1.01, 2.00)]. Similarly, 
major/contraindicated DDIs among Non-TCM intervention members were more 
likely to be resolved than Non-TCM control members [OR= 1.89 (1.12, 3.18)]. No 
significant differences were found in terms of hospital or ER visits for TCM and 
Non-TCM groups. ConClusions: A successful collaboration between pharmacists 
and nurses significantly improved the resolution of drug-related issues in a com-
mercial population.
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objeCtives: The primary aim was to describe the various patient centered medical 
home (PCMH) models and discuss the roles for pharmacists. A secondary aim was to 
discuss implementation strategies and potential barriers. Methods: A literature 
search accessed articles published from 2008 to 2013 through electronic databases 
PubMed, pharmacy association websites, and the Agency for Healthcare Research 
and Quality website. Key terms utilized in the search were “PCMH” and “pharma-
cists.” Articles without a description of a PCMH model were excluded. The refer-
ence list of each article was searched for additional related articles. Results were 
summarized in a table, which included the year of publication, author, title, study 
design, source and findings. Results: Thirty-one articles were included in this 
review with subtopics; role of the pharmacist, implementation strategies and bar-
riers. Literature review suggests that while pharmacists can make positive impacts 
both financially and in patient outcomes, the current system and infrastructure 
may make support of a pharmacist difficult. Significant changes in a PCMH model 
must be integrated for pharmacist participation. Specifically, a pharmacist’s scope 
of practice should be established. Major themes included pharmacist collaboration 
with other health professionals, the provision of medication therapy management 
services, and chronic disease management. Implementation strategies that proved 
to be successful were consistent in allowing for open communication between 
the pharmacist and the team, a clearly defined structure for reimbursement, and 
taking an active role in monitoring or quality improvements. Barriers are related 
to reimbursement, health information technology and collaborative practice agree-
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at an acceptable cost. The objective of this study was to perform a rapid-HTA to 
evaluate the effectiveness of integrated care in reducing the mortality rate of breast 
cancer. Methods: A literature review was performed via PubMed, LILACS, the 
Cochrane Library, Center of Reviews and Dissemination, and REBRATS databases. All 
studies that met the inclusion criteria were appraised according to the GRADE and 
their level of evidence according to the Oxford Centre for Evidence Based Medicine. 
This HTA was performed following the “Rapid-HTA Guideline” published by the 
Brazilian Ministry of Health. Results: 242 studies were retrieved among those 
databases. 3 cohort studies and 1 systematic review met the inclusion criteria. One 
cohort study associated a reduction in the mortality rate, statistically significant, 
after the implementation of the breast cancer integrated care. The systematic review 
concluded that there are few high quality studies evaluating the impact of integrated 
care on the breast cancer mortality. However, its authors didn’t challenge the impact 
of integrated care on the breast cancer management nor its potential psychosocial 
benefits. Intrinsically, they stated, this type of disease management is associated 
to a low rate of mortality, but there is a lack of high quality studies. ConClusions: 
There are few studies assessing the effectiveness of breast cancer integrated care 
programs in reducing the mortality rate among those women. The final recom-
mendation is weak in favor of this health technology and we suggest a systematic 
review to search and evaluate the existing evidence.
PHS149
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objeCtives: The Affordable Care Act (ACA) was signed into law on March 23, 2010. 
The ACA was developed to increase affordability and accessibility to health care. 
The purpose of this review was to provide an overview of the impact of the ACA 
on pharmacy benefit managers (PBMs) with respect to benefit design changes, 
health care exchanges and challenges. Methods: PubMed, Google Scholar, APhA 
and AMCP websites were searched for articles from 2008 to 2013. This timeframe 
was selected because the ACA became officially recognized in 2010, when signed 
into law. Keywords used in the search were “pharmacy model”, “affordable care 
act”, “pharmacy benefit”, “benefit design changes”, “health care exchange”, and 
“outcomes.” Each reference was evaluated against the following inclusion crite-
ria using a step-wise approach; 1) the article included information on formulary 
changes, health care exchanges or projected outcomes 2) the article mentioned 
benefit designs and pharmacy benefit managers. Articles were summarized based 
upon publication year, methods and findings. Results: A total of 24 articles were 
retrieved. Studies show that there will be 25-30 million newly insured patients over 
7-8 years as a result of the ACA. PBMs will continue to be interested in increasing 
coverage of generic products on plan formularies. The number of medications and 
types of diseases covered through the growth of specialty pharmacy is also projected 
to increase. Under the ACA exchanges, PBMs are required to confidentially disclose 
the percent of all prescriptions provided through retail pharmacies and the types of 
rebates and discounts received. Although challenging, PBMs can expect increases in 
mergers, creating larger PBM companies. ConClusions: With an increase in the 
number of members covered and types of coverage offered, the Affordable Care Act 
is projected to have positive effects on the growth and expansion of services offered 
by PBMs. However, PBMs may face challenges accommodating larger populations.
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iMPAct of educAtionAl intervention on QuAlity of life of PAtientS 
neArinG end of life: An evidence BASed AnAlySiS
Nevis I.F., Sikich N., Holubowich C.
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objeCtives: To systematically review studies that include educational interven-
tions for health care providers, patients nearing the end-of-life (EoL), and their car-
egivers to improve patient or caregiver quality of life (QoL). Methods: This review 
was conducted according to published guidelines using a pre-specified protocol. 
Patients nearing EOL were defined as having a progressive, life-threatening disease 
with minimal possibility of obtaining remission, stabilization or modification of the 
course of illness. Primary studies including any educational intervention in EoL care 
among health care providers, patients and caregivers measuring patient or caregiver 
QoL using validated scales were included. Results: Our search of 11 databases 
revealed 2468 citations. After duplicate removal, title and abstract screening, we 
reviewed 71 full text of which eight were included in the review. There were five 
randomised trials, two cohort studies and one quasi experimental study among 
the eight included studies. Five studies were from United States, one each from 
Spain, Saudi Arabia and China. Patient population included those with advanced 
cancer in five studies (4 RCT’S and 1 cohort study) and advanced chronic disease in 
three studies (1 cluster randomised, 1 quasi-experimental and 1 cohort study). The 
educational intervention was described among clinicians, nurses, EoL patients and 
their caregivers. Comparators were usual/standard care in five studies with a pre-
post impact evaluation in three other studies. All included studies defined and used 
validated scales to measure QoL. Patient QoL was reported in seven of the included 
studies, of which four studies showed improvement (P< 0.001) and three showed 
no significant change (p> 0.05) in patient’s QoL. Of the four studies that reported 
caregiver QoL, three showed improved QoL whereas one study showed decline in 
caregivers QoL (p= 0.02). ConClusions: This review may help shape Ontario health 
policy to provide appropriate education to anyone involved in EoL care.
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MAMMoGrAPHy PreScriPtionS in united StAteS PriMAry cAre SettinG – 
PHySiciAn’S coMPliAnce WitH GuidelineS
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TIP-records, time period, beneficiary age, gender, and drug plan (MA-PD, PDP). A 
generalized linear mixed model was fitted for the assessment, using AIC for model 
selection. Results: Each additional TIP-record generated was significantly associ-
ated with a higher total drug cost (p < .0001); however, this effect was attenuated 
over time, as would be expected when the TIP-record was successfully acted upon. 
A successful TIP-record was associated with an 18% reduction in cost at the begin-
ning of the study, falling to 7% at 18 months. On average, MA-PD beneficiaries had 
a cost which was 1.62 times higher than those from the PDP; male beneficiaries had 
an average cost which was 4.8% higher than their counterparts. ConClusions: 
Cost-management TIP-records demonstrated a significant decrease in total pre-
scription drug cost upon successful completion, suggesting targeted medication 
reviews could be used as a drug cost saving strategy for Medicare Part D plans.
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objeCtives: While the use of acupuncture services covered by National Health 
Insurance (NHI) in Taiwan increased, it is unclear how reasonable its utilization is. 
The aim of this study was to explore the acupuncture service utilization among the 
elderly and its potential contributing factors. Methods: The retrospective cohort 
study was conducted using two million random samples of Taiwan National Health 
Insurance Research Databases. Those elderly patients without cancer diseases and 
ever used acupuncture services among the Chinese medicine (CM) users in 2008 
were considered as acupuncture users. Their counterpart non-acupuncture elderly 
CM users were identified based upon the pre-specified propensity score matching 
approach. The demographic characteristics, disease statuses, health care utiliza-
tion, anti-blood clotting medications, pain medications among these two groups 
were compared using descriptive statistics, Chi-square and ANOVA. The univariate 
and multivariate logistic regression tests were performed to explore the factors 
associated with the ever use of acupuncture services. Results: Of 47,273 elderly 
patients ever used CM service , 12520 (32.3%) ever utilized acupuncture services 
in 2008. 12,494 elderly patients in each group were identified. After adjusting for 
other factors, those CM use elderly who made outpatients visits more than 2 times, 
with neurovascular diseases, diabetes mellitus, lower back pain, ever took aspirin, 
warfarin, NSAID, gabapentin during six months before the first use of CM tended 
to use acupuncture services. In contrast, those CM use elderly who were aged 
75 to 84, prescribed with more than 10 items of medications, with chronic lung 
disorders, osteoporosis tended not to use acupuncture services. ConClusions: 
Approximately one-third of CM use elderly ever made acupuncture services. More 
attention should be made towards those patients who made more outpatient visits, 
with certain chronic disorders and ever took blood-clotting and pain medications. 
Further study to explore the corresponding outcomes of acupuncture uses among 
the elderly is needed.
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WHAt deterMinAntS HelP Predict reAdMiSSion in A teAcHinG HoSPitAl
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objeCtives: Reducing readmissions is a National Health Service (NHS) Key 
Performance Indicator. Ambulatory care units may provide financial savings, but 
high quality and effective service delivery is dependent on having an understanding 
of an individual hospital’s admissions. Comparison of patients with single or mul-
tiple comorbidities on admission or in other words multiple admission diagnoses, 
may help plan and deliver appropriate health care and support services in the most 
appropriate setting. We compared patients with multiple admission diagnoses to 
patients with one single admission diagnosis, to investigate whether there are dif-
ferences in patient demographics, length of stay and readmission. Methods: We 
conducted a retrospective audit of all non-elective adult acute medical admissions 
over a 6 week period. We collected information on patient demographics, ICD-10 
diagnosis and length of hospital stay. We reviewed all electronic discharge sum-
maries and grouped admissions according to ICD-10 classification. We matched 
patients with multiple diagnoses to patients with similar ICD-10 diagnosis, without 
other co-morbidities. The length of stay, and readmission rates were also recorded 
and compared. Results: A total of 863 admissions were analysed. We matched 41 
patients with multiple co-morbidities and same admission diagnoses to patients 
discharged with a comparable single ICD-10 diagnosis. Both groups had similar 
female to male ratio. The mean age in both groups was 65 (p= 0.42). However, the 
length of stay was statistically significant (p= 0.002) between the two groups (multi-
ple diagnosis 12 days vs 6 days for single diagnosis). Moreover, patients with multiple 
admission diagnoses had higher readmission rates within a week and a month (0 
patients with single admission diagnosis vs 5 patients with multiple admission diag-
noses). ConClusions: Both groups had similar demographics, but co-morbidities 
can lead to longer hospital stay, and increase risk of hospital readmission. Patients 
with multiple co-morbidities should have more detailed discharged planning by 
multidisciplinary team. Patients without multiple co-morbidites can be safely man-
aged in an ambulatory care setting.
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BreASt cAncer inteGrAted cAre: A rAPid-HtA
Cachoeira C.V., Andrade P.C., Junqueira S.M., Repsold D.M.
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objeCtives: Breast cancer is one of the commonest cancers worldwide. The care 
management of patients with cancer is complex, which may lead to suboptimal, 
fragmented and discontinuous treatment. Integrated care pathways have begun 
to receive greater attention and support because of the possibility to reduce this 
fragmentation and achieve better results for the patient and the health care system 
